Fig. 2
The expression levels of (a) CSK, (b) GSK3β, (c) MAP3K14, (d) PLCG1, (e) PTPN6, (f) SLP-76, (g) TAK1 in ACs patients compared to healthy (normal) group
Fig. 2 | Infectious Agents and Cancer
The expression levels of (a) CSK, (b) GSK3β, (c) MAP3K14, (d) PLCG1, (e) PTPN6, (f) SLP-76, (g) TAK1 in ACs patients compared to healthy (normal) group